Aronex Pharmaceuticals clinical trials
Acquired by Agenus Inc., Jul 12, 2001 · source ↗
The registry lists 6 studies whose lead sponsor is Aronex Pharmaceuticals. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 26, 2013.
Before and after it joined Agenus Inc.
- First submitted before Aronex Pharmaceuticals became part of Agenus Inc.
- 2
- First submitted after Aronex Pharmaceuticals became part of Agenus Inc.
- 4
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Aronex Pharmaceuticals6 studies
Something wrong with this grouping? Tell us on the Agenus Inc. page.
Studies
Recruiting first, then most recently updated. Showing 6 of 6. All Agenus Inc. studies →
- Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic CancerCompletedNCT00002742Phase 3
Sponsor listed in the registry: Aronex Pharmaceuticals · First submitted before Aronex Pharmaceuticals became part of Agenus Inc.
- Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard TherapiesStatus unknownNCT00081536Phase 1/2
Sponsor listed in the registry: Aronex Pharmaceuticals · First submitted after Aronex Pharmaceuticals became part of Agenus Inc.
- Aroplatin and Gemcitabine in Patients With Advanced Pancreatic Cancer Resistant to Standard TherapiesStatus unknownNCT00081549Phase 1/2
Sponsor listed in the registry: Aronex Pharmaceuticals · First submitted after Aronex Pharmaceuticals became part of Agenus Inc.
- A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid MalignanciesStatus unknownNCT00057395Phase 1/2
Sponsor listed in the registry: Aronex Pharmaceuticals · First submitted after Aronex Pharmaceuticals became part of Agenus Inc.
- A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Colorectal Cancer Resistant to Standard TherapiesStatus unknownNCT00043199Phase 2
Sponsor listed in the registry: Aronex Pharmaceuticals · First submitted after Aronex Pharmaceuticals became part of Agenus Inc.
- Safety and Effectiveness of Zintevir (AR177) Given to HIV-Infected PatientsCompletedNCT00002403Phase 1
Sponsor listed in the registry: Aronex Pharmaceuticals · First submitted before Aronex Pharmaceuticals became part of Agenus Inc.